Judah Frommer
Stock Analyst at Morgan Stanley
(3.71)
# 2,076
Out of 4,988 analysts
490
Total ratings
53.1%
Success rate
3.8%
Average return
Main Sectors:
Stocks Rated by Judah Frommer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLDX Celldex Therapeutics | Rated: Buy | $46 → $50 | $38.24 | +30.75% | 12 | Sep 10, 2026 | |
| AGMB AgomAb Therapeutics NV | Reiterated: Buy | $28 | $12.17 | +130.07% | 10 | Sep 8, 2026 | |
| ATTO Attovia Therapeutics | Rated: Buy | $39 | $22.14 | +76.15% | 2 | Sep 3, 2026 | |
| LKFT Lakefront Biotherapeutics NV | Rated: Hold | $26 | $28.55 | -8.93% | 56 | Aug 31, 2026 | |
| QTTB Q32 Bio | Initiated Coverage: Buy | $34 | $10.54 | +222.58% | 1 | Aug 24, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $18 | $8.03 | +124.16% | 22 | Aug 24, 2026 | |
| BLTE Belite Bio | Reiterated: Buy | $201 → $206 | $170.96 | +20.50% | 3 | Aug 17, 2026 | |
| FDMT 4D Molecular Therapeutics | Rated: Hold | n/a | $15.22 | - | 14 | Aug 17, 2026 | |
| ZBIO Zenas BioPharma | Reiterated: Hold | $22 → $32 | $31.50 | +1.59% | 12 | Aug 17, 2026 | |
| AVLN Avalyn Pharma | Rated: Buy | $53 → $57 | $31.52 | +80.84% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $22.64 | +63.43% | 19 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $1.91 | - | 10 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $14 | $3.20 | +337.50% | 4 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $19 | $12.50 | +52.00% | 2 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $1.91 | +57.07% | 15 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 | $9.65 | +169.43% | 9 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $23 | $14.95 | +53.85% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 | $34.74 | +0.75% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $34 → $38 | $25.38 | +49.72% | 7 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $18 | $15.19 | +18.50% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $119 → $135 | $117.75 | +14.65% | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93 → $104 | $65.37 | +59.09% | 27 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $104 → $119 | $125.31 | -5.04% | 14 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $132 → $180 | $105.04 | +71.36% | 7 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $141 → $139 | $20.11 | n/a | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $138 | $0.0002 | n/a | 9 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.89 | n/a | 8 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $0.6178 | n/a | 8 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $28.43 | n/a | 7 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $22 | $22.49 | n/a | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $10.85 | n/a | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $13 | $2.65 | n/a | 4 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $11 → $8 | $3.76 | n/a | 9 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $55 | $44.00 | n/a | 6 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $46 | $120.00 | n/a | 3 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3.5 | $29.48 | n/a | 1 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $24 | $93.42 | n/a | 7 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 → $26 | $70.79 | n/a | 10 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $12.35 | n/a | 2 | Jul 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $90 → $95 | $75.84 | n/a | 10 | Jul 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $328 | $895.31 | n/a | 6 | Jul 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 | $60.00 | n/a | 28 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $125 → $116 | $234.14 | n/a | 9 | Jun 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €22.00 → €24.00 | €31.60 | n/a | 3 | Jun 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $98 → $107 | $111.96 | n/a | 19 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $154 → $178 | $122.41 | n/a | 10 | May 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 → $38 | $92.03 | n/a | 4 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $67 → $63 | $79.05 | n/a | 17 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $91.93 | n/a | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.12 | n/a | 1 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $36.29 | n/a | 1 | Mar 6, 2019 |
Celldex Therapeutics
Sep 10, 2026
Rated: Buy
Price Target: $46 → $50
Current: $38.24
Upside: +30.75%
AgomAb Therapeutics NV
Sep 8, 2026
Reiterated: Buy
Price Target: $28
Current: $12.17
Upside: +130.07%
Attovia Therapeutics
Sep 3, 2026
Rated: Buy
Price Target: $39
Current: $22.14
Upside: +76.15%
Lakefront Biotherapeutics NV
Aug 31, 2026
Rated: Hold
Price Target: $26
Current: $28.55
Upside: -8.93%
Q32 Bio
Aug 24, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $10.54
Upside: +222.58%
REGENXBIO
Aug 24, 2026
Reiterated: Buy
Price Target: $18
Current: $8.03
Upside: +124.16%
Belite Bio
Aug 17, 2026
Reiterated: Buy
Price Target: $201 → $206
Current: $170.96
Upside: +20.50%
4D Molecular Therapeutics
Aug 17, 2026
Rated: Hold
Price Target: n/a
Current: $15.22
Upside: -
Zenas BioPharma
Aug 17, 2026
Reiterated: Hold
Price Target: $22 → $32
Current: $31.50
Upside: +1.59%
Avalyn Pharma
Aug 13, 2026
Rated: Buy
Price Target: $53 → $57
Current: $31.52
Upside: +80.84%
Aug 12, 2026
Reiterated: Buy
Price Target: $37
Current: $22.64
Upside: +63.43%
Aug 12, 2026
Reiterated: Sell
Price Target: n/a
Current: $1.91
Upside: -
Aug 12, 2026
Rated: Buy
Price Target: $14
Current: $3.20
Upside: +337.50%
Aug 11, 2026
Rated: Buy
Price Target: $20 → $19
Current: $12.50
Upside: +52.00%
Aug 11, 2026
Reiterated: Hold
Price Target: $3
Current: $1.91
Upside: +57.07%
Aug 10, 2026
Rated: Buy
Price Target: $26
Current: $9.65
Upside: +169.43%
Aug 10, 2026
Rated: Buy
Price Target: $20 → $23
Current: $14.95
Upside: +53.85%
Aug 7, 2026
Reiterated: Hold
Price Target: $35
Current: $34.74
Upside: +0.75%
Aug 6, 2026
Rated: Buy
Price Target: $34 → $38
Current: $25.38
Upside: +49.72%
Aug 6, 2026
Reiterated: Buy
Price Target: $17 → $18
Current: $15.19
Upside: +18.50%
Aug 6, 2026
Rated: Buy
Price Target: $119 → $135
Current: $117.75
Upside: +14.65%
Jul 31, 2026
Reiterated: Buy
Price Target: $93 → $104
Current: $65.37
Upside: +59.09%
Jul 29, 2026
Reiterated: Hold
Price Target: $104 → $119
Current: $125.31
Upside: -5.04%
Jul 24, 2026
Rated: Buy
Price Target: $132 → $180
Current: $105.04
Upside: +71.36%
Aug 3, 2023
Reiterated: Hold
Price Target: $141 → $139
Current: $20.11
Upside: n/a
Jun 5, 2023
Reiterated: Buy
Price Target: $138
Current: $0.0002
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $13
Current: $4.89
Upside: n/a
May 15, 2023
Reiterated: Buy
Price Target: $40
Current: $0.6178
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $28
Current: $28.43
Upside: n/a
Apr 3, 2023
Reiterated: Buy
Price Target: $21 → $22
Current: $22.49
Upside: n/a
Mar 31, 2023
Reiterated: Buy
Price Target: $8 → $7
Current: $10.85
Upside: n/a
Mar 28, 2023
Reiterated: Buy
Price Target: $16 → $13
Current: $2.65
Upside: n/a
Mar 9, 2023
Downgraded: Hold
Price Target: $11 → $8
Current: $3.76
Upside: n/a
Feb 28, 2023
Reiterated: Buy
Price Target: $51 → $55
Current: $44.00
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $57 → $46
Current: $120.00
Upside: n/a
May 11, 2022
Reiterated: Sell
Price Target: $3.5
Current: $29.48
Upside: n/a
Aug 4, 2020
Reiterated: Buy
Price Target: $23 → $24
Current: $93.42
Upside: n/a
Jul 30, 2020
Reiterated: Hold
Price Target: $22 → $26
Current: $70.79
Upside: n/a
Jul 27, 2020
Reiterated: Buy
Price Target: $18
Current: $12.35
Upside: n/a
Jul 22, 2020
Rated: Hold
Price Target: $90 → $95
Current: $75.84
Upside: n/a
Jul 8, 2020
Reiterated: Hold
Price Target: $328
Current: $895.31
Upside: n/a
Jun 18, 2020
Reiterated: Hold
Price Target: $35
Current: $60.00
Upside: n/a
Jun 10, 2020
Rated: Buy
Price Target: $125 → $116
Current: $234.14
Upside: n/a
Jun 3, 2020
Reiterated: Hold
Price Target: €22.00 → €24.00
Current: €31.60
Upside: n/a
May 28, 2020
Rated: Buy
Price Target: $98 → $107
Current: $111.96
Upside: n/a
May 22, 2020
Reiterated: Hold
Price Target: $154 → $178
Current: $122.41
Upside: n/a
May 21, 2020
Rated: Buy
Price Target: $31 → $38
Current: $92.03
Upside: n/a
May 5, 2020
Rated: Buy
Price Target: $67 → $63
Current: $79.05
Upside: n/a
May 4, 2020
Reiterated: Buy
Price Target: $39
Current: $91.93
Upside: n/a
Mar 6, 2020
Downgraded: Hold
Price Target: n/a
Current: $14.12
Upside: n/a
Mar 6, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $36.29
Upside: n/a